Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients
Clinical trial NCT06556004 · UNKNOWN
Trial details
- NCT number
- NCT06556004
- Sponsor
- University of Chile
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-02
- Primary completion
- 2023-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.